Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Aug 28, 2026

VIR — Vir Biotechnology, Inc. Dilution Risk Tracker

Track VIR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VIR — Get alerts when the score changes →

As of August 28, 2026, Vir Biotechnology, Inc. (VIR) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Vir Biotechnology, Inc. has a market capitalization of $1.61B, 169.22M shares outstanding, 257 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $300.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
32
💰 Cash Runway
40
📊 Float Risk
22
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $300M remaining capacity
🔔 Track VIR — Get forecast alerts →

Market Data

Market Cap$1.61B
Shares Outstanding169.22M
Float128.81M
Cash$528.59M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 36.4% shares (2026Q1 vs prior)
257 institutional holders · 160.50M shares
#1 BlackRock, Inc. 18.00M shares
#2 ARCH Venture Management, LLC 12.92M shares
#3 SB INVESTMENT ADVISERS (UK) LTD 10.95M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest19.04M
Days to Cover12.2
% of Float14.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2019-12-31
4 INSIDER TRANSACTION 2026-04-07
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-03-24
4 INSIDER TRANSACTION 2026-03-23
Full SEC filing analysis available with free account

Recent News

No recent news

Factual VIR Dilution Snapshot

Vir Biotechnology, Inc. (VIR) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track VIR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VIR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for VIR
VIR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.